Voxel-wise analysis of dynamic 18F-FET PET: a novel approach for non-invasive glioma characterisation

Abstract

BackgroundGlioma grading with dynamic 18F-FET PET (0–40 min p.i.) is typically performed by analysing the mean time-activity curve of the entire tumour or a suspicious area within a heterogeneous tumour. This work aimed to ensure a reader-independent glioma characterisation and identification of aggressive sub-volumes by performing a voxel-based analysis with diagnostically relevant kinetic and static 18F-FET PET parameters.One hundred sixty-two patients with a newly diagnosed glioma classified according to histologic and molecular genetic properties were evaluated. The biological tumour volume (BTV) was segmented in static 20–40 min p.i. 18F-FET PET images using the established threshold of 1.6 × background activity. For each enclosed voxel, the time-to-peak (TTP), the late slope (Slope15–40), and the tumour-to-background ratios (TBR5–15, TBR20–40) obtained from 5 to 15 min p.i. and 20 to 40 min p.i. images were determined. The percentage portion of these values within the BTV was evaluated with percentage volume fractions (PVFs) and cumulated percentage volume histograms (PVHs). The ability to differentiate histologic and molecular genetic classes was assessed and compared to volume-of-interest (VOI)-based parameters.ResultsAggressive WHO grades III and IV and IDH-wildtype gliomas were dominated by a high proportion of voxels with an early peak, negative slope, and high TBR, whereby the PVHs with TTP < 20 min p.i., Slope15–40 < 0 SUV/h, and TBR5–15 and TBR20–40 > 2 yielded the most significant differences between glioma grades. We found significant differences of the parameters between WHO grades and IDH mutation status, where the effect size was predominantly higher for voxel-based PVHs compared to the corresponding VOI-based parameters. A low overlap of BTV sub-volumes defined by TTP < 20 min p.i. and negative Slope15–40 with TBR5–15 > 2- and TBR20–40 > 2-defined hotspots was observed.ConclusionsThe presented approach applying voxel-wise analysis of dynamic 18F-FET PET enables an enhanced characterisation of gliomas and might potentially provide a fast identification of aggressive sub-volumes within the BTV. Parametric 3D 18F-FET PET information as investigated in this study has the potential to guide individual therapy instrumentation and may be included in future biopsy studies.Electronic supplementary materialThe online version of this article (10.1186/s13550-018-0444-y) contains supplementary material, which is available to authorized users.

An update on PET-based molecular imaging in neuro-oncology: challenges and implementation for a precision medicine approach in cancer care

“…Of the remarkable progress in advanced molecular profiling and genomic characterization in brain tumors, particularly in gliomas, was the revision of the classification and management of gliomas toward molecular profiling and genomic characterization by WHO in 2016 (1). Vomacka and colleagues (26) have intended to ascertain a readerindependent glioma detection and characterization of aggressive sub-component through a voxel-wise analysis of diagnostically-related static and kinetic 18 F-FET PET values. 162 subjects with newly diagnosed gliomas were enrolled and were separated into groups upon histologic, genetic, and molecular characteristics.…”

Dynamic amino-acid PET in neuro-oncology: a prognostic tool becomes essential

“…There have been previous reports of voxel-wise analysis in dynamic acquisitions of amino-acid PET imaging in gliomas [34][35][36]. But the Li et al study differs from these previous investigations because it evaluates the textural features of TTP parametric images, i.e.…”

Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in Gliomas

“…In this context, it will be essential to assess the relevance of the different hotspots detectable within the various modalities, and semiquantitative parametric maps taking into account dynamic PET and MRI information could provide further important insights, which have proven relevance for e.g. glioma classification [54].…”